Serum oxidative-antioxidative status in patients with ankylosing spondilitis

Rheumatology International

Volumn 27, Issue 12, 2007, Pages 1131-1134

  Karakoc, Mehmet ^a   Altindag, Ozlem ^b   Keles, Huseyin ^b   Soran, Neslihan ^b   Selek, Sahabettin ^b  

^a Ozel Yasam Hospital   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; Antioxidants; Oxidative stress; Spondyloarthropathies

Indexed keywords

ANTIOXIDANT; OXIDIZING AGENT;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; ANTIOXIDANTS; FEMALE; HUMANS; MALE; OXIDATIVE STRESS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 34548476472     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0352-3     Document Type: Article

References (21)

1. Ho KJ, Chen PQ, Chang CY, Lu FJ (2000) The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence. Ann Rheum Dis 59:338-341
2. Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O (2004) Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 24:80-83
3. Karakucuk S, Baskol G, Oner AO, Baskol M, Mirza E, Ustdal M (2004) Serum paraoxonase activity is decreased in the active stage of Behcet's disease. Br J Ophthalmol 88:1256-1258
4. Sarban S, Kocyigit A, Yazar M, Isikan UE (2005) Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38:981-986
5. Harma M, Harma M, Erel O (2003) Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 133:563-536
6. Tak PP, Zvaifler NJ, Green DR, Firestein GS (2000) Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 21:78-82
7. Lunec J, Halloran SP, White AG, Dormandy TL (1981) Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 8:233-245
8. Blake DR, Merry P, Unsworth J, Ballard R, Morris CJ, Gray L, Lunec J (1989) Hypoxic-reperfusion injury in the inflamed human joint. Lancet 11:289-293
9. Biasi D, Carletto A, Caramaschi P, Caramaschi P, Zeminian S, Bambara LM (1995) Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients. Clin Exp Rheumatol 13:623-627
10. Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 38:878-882
11. Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277-285
12. Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103-1111
13. Wendling D, Didier JM, Vuitton DA (1991) The phagocyte oxidative metabolism function in ankylosing spondylitis. Rheumatol Int 11:187-189
14. Henrotin YE, Bruckner P, Pujol JP (2003) The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr Cartil 11:747-755
15. Hitchon CA, El-Gabalawy HS (2004) Oxidation in rheumatoid arthritis. Arthr Res Ther 6:265-278
16. Yazici C, Kose K, Calis M, Kuzuguden S, Kirnap M (2004) Protein oxidation status in patients with ankylosing spondylitis. Rheumatology (Oxford) 43:1235-1259
17. Mungan AG, Can M, Acikgoz S, Esturk E, Altinyazar C (2006) Lipid peroxidation and homocysteine levels in Behcet's disease. Clin Chem Lab Med 44:1115-1118
18. Tutuncu ZN, Bilgie A, Kennedy LG, Calin A (1994) Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. Ann Rheum Dis 53:425-426
19. Stichtenoth DO, Wollenhaupt J, Andersone D, Zeidler H, Frolich JC (1995) Elevated serum nitrate concentrations in active spondyloarthropathies. Br J Rheumatol 34:616-619
20. Griffiths HR (2005) ROS as signalling molecules in T cells-evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis. Redox Rep 10:273-280
21. Pham TN, Rahman P, Tobin YM, Khraishi MM, Hamilton SF, Alderdice C, Richardson VJ (2003) Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in peripheral blood monocyte-derived macrophages. J Rheumatol 30:2529-2534